Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
Clinical Lymphoma, Myeloma & Leukemia|March 22, 2020
Ibrutinib-associated Arthralgias/Myalgias in Patients With Chronic Lymphocytic Leukemia: Incidence and Impact on Clinical OutcomesJoanna M Rhodes, Vincent A LoRe, Anthony R Mato, et al.
Cancer Discovery|March 20, 2020
Mutations in the RNA Splicing Factor SF3B1 Promote Tumorigenesis through MYC StabilizationZhaoqi Liu, Akihide Yoshimi, Jiguang Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 30, 2025
Ferroptosis: An emerging strategy for managing epithelial ovarian cancerC Alarcón-Veleiro, I López-Calvo, L Berjawi, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 9, 2020
Prognostic Testing and Treatment Patterns in Chronic Lymphocytic Leukemia in the Era of Novel Targeted Therapies: Results From the informCLL RegistryAnthony R Mato, Jacqueline C Barrientos, Nilanjan Ghosh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2022
Functional Testing to Characterize and Stratify PI3K Inhibitor Responses in Chronic Lymphocytic LeukemiaYanping Yin, Paschalis Athanasiadis, Linda Karlsen, et al.
American Journal of Hematology|February 22, 2023
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b studyScott F Huntington, Stephen J Schuster, Wei Ding, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 25, 2018
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment RegimenNirav N Shah, Aniko Szabo, Raya Saba, et al.
Haematologica|March 30, 2019
Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapyAnthony R Mato, William G Wierda, Matthew S Davids, et al.
The New England Journal of Medicine|December 12, 2017
Chimeric Antigen Receptor T Cells in Refractory B-Cell LymphomasStephen J Schuster, Jakub Svoboda, Elise A Chong, et al.
Blood|November 3, 2016
Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCTChristine E Ryan, Bita Sahaf, Aaron C Logan, et al.
Pageof 12